Catherine M. Szyman - 07 May 2021 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, Critical Care
Signature: Linda J. Park, Attorney-in-Fact
Issuer symbol: EW
Transactions as of: 07 May 2021
Net transactions value: -$39,269
Form type: 4
Filing time: 11 May 2021, 10:03:32 UTC
Next filing: 12 May 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Tax liability	$39,269	-428	-1.2%	$91.75	33,901	07 May 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Does not reflect transactions effected on May 7, 2021 pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2020, which transactions were reported on a Form 4 filed with the SEC on May 7, 2021. The actual amount of securities beneficially owned by the Reporting Person following transaction reported on this Form 4 is 30,512.2148.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.